- Report
- May 2025
North America
From €1904EUR$2,095USD£1,617GBP
€3627EUR$3,990USD£3,080GBP
From €1904EUR$2,095USD£1,617GBP
€3627EUR$3,990USD£3,080GBP
- Report
- May 2025
Middle East
From €1904EUR$2,095USD£1,617GBP
€3627EUR$3,990USD£3,080GBP
- Report
- May 2025
Asia Pacific
From €1904EUR$2,095USD£1,617GBP
€3627EUR$3,990USD£3,080GBP
- Report
- May 2025
United States
From €1904EUR$2,095USD£1,617GBP
€3627EUR$3,990USD£3,080GBP
- Report
- May 2025
United Kingdom
From €1904EUR$2,095USD£1,617GBP
€3627EUR$3,990USD£3,080GBP
From €1904EUR$2,095USD£1,617GBP
€3627EUR$3,990USD£3,080GBP
- Report
- April 2025
Europe
From €3627EUR$3,990USD£3,080GBP
- Report
- March 2025
- 92 Pages
Global
From €3500EUR$4,125USD£3,076GBP
- Report
- March 2025
- 79 Pages
Global
From €3500EUR$4,125USD£3,076GBP
- Report
- March 2025
- 85 Pages
Global
From €3500EUR$4,125USD£3,076GBP
- Report
- January 2025
- 85 Pages
Global
From €3500EUR$4,125USD£3,076GBP
- Report
- November 2024
- 78 Pages
Global
From €3500EUR$4,125USD£3,076GBP
- Report
- November 2024
- 104 Pages
Global
From €3500EUR$4,125USD£3,076GBP
- Report
- November 2024
- 109 Pages
Global
From €3500EUR$4,125USD£3,076GBP
- Report
- October 2024
- 96 Pages
Global
From €3500EUR$4,125USD£3,076GBP
- Report
- October 2024
- 88 Pages
Global
From €3500EUR$4,125USD£3,076GBP
- Report
- October 2024
- 78 Pages
Global
From €3500EUR$4,125USD£3,076GBP
- Report
- October 2024
- 104 Pages
Global
From €3500EUR$4,125USD£3,076GBP
- Report
- October 2024
- 85 Pages
Global
From €3500EUR$4,125USD£3,076GBP

The Vaccines market is a sector of the pharmaceutical industry that focuses on the development, production, and distribution of vaccines. Vaccines are used to prevent and treat infectious diseases, and are an important part of public health initiatives. Vaccines are typically developed by pharmaceutical companies, and then approved by regulatory bodies such as the US Food and Drug Administration (FDA).
The Vaccines market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, and Johnson & Johnson. These companies are involved in the development, production, and distribution of a wide range of vaccines, including those for influenza, measles, mumps, rubella, and hepatitis. Smaller companies are also involved in the Vaccines market, such as Emergent BioSolutions and Bavarian Nordic. Show Less Read more